Atrial cardiomyopathy and incident ischemic stroke risk: a systematic review and meta-analysis

Jiahuan Guo1, Dandan Wang1, Jiaokun Jia1

  • 1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Fanyang Street 119, Beijing, 100070, China.

Journal of Neurology
|April 4, 2023
PubMed

Insights

Atrial cardiomyopathy markers like P-terminal force in V1, P-wave area, left atrial diameter, and NT-proBNP can predict ischemic stroke risk. These markers aid in stratifying stroke risk for better patient management.

Area of Science:

  • Cardiology
  • Neurology
  • Biomarker Research

Background:

  • Atrial cardiomyopathy is increasingly recognized for its role in thrombosis and ischemic stroke.
  • Quantifying atrial cardiomyopathy markers is crucial for predicting ischemic stroke risk.

Approach:

  • Systematic review and meta-analysis of 25 longitudinal cohort studies.
  • Involved 262,504 individuals, analyzing electrocardiographic, structural, functional, and serum biomarkers.
  • Searched PubMed, Embase, and Cochrane Library for relevant studies.

Key Points:

  • P-terminal force in V1 (PTFV1), P-wave area, and left atrial (LA) diameter are independent predictors of ischemic stroke.
  • LA reservoir strain and N-terminal pro-brain natriuretic peptide (NT-proBNP) also show significant associations with stroke risk.
  • Various markers, including PTFV1 (HR 1.29), max P-wave area (HR 1.14), LA diameter (HR 1.39), LA reservoir strain (HR 0.88), and NT-proBNP (HR 2.37), demonstrated predictive value.

Conclusions:

  • Electrocardiographic, serum, and LA structural/functional markers of atrial cardiomyopathy are valuable for risk stratification.
  • These markers can identify individuals at higher risk of incident ischemic stroke.
  • Utilizing these biomarkers can improve the prediction and management of ischemic stroke.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
26
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
29
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
16
Cardiac Output II: Effect of Stroke Volume on Cardiac Output01:22

Cardiac Output II: Effect of Stroke Volume on Cardiac Output

Cardiac output (CO), the amount of blood the heart pumps per minute, is a parameter in cardiovascular physiology determined by stroke volume and heart rate. Stroke volume, the amount of blood pushed from one of the ventricles per heartbeat, is influenced by preload, afterload, and contractility.
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
19